PHAT
NASDAQ · Pharmaceuticals
Phathom Pharmaceuticals Inc
$10.06
-0.51 (-4.83%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+404.4% upside
Low Target
$34.41
Average Target
$50.74
High Target
$70.04
Current Price
$10.06
Current
$10.06
$10.06
Target
$50.74
$50.74
$34.41
$50.74 avg
$70.04
Scenario Analysis
Bear Case
$34.41
242.0%
Low target
Base Case
$50.74
+404.4%
Avg target
Bull Case
$70.04
+596.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$18.31
-45.1% from high
52-Week Low
$2.21
+355.2% from low
Target vs 52W High
$50.74
+177.1% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |